Jordan Madic

1.5k citations

18 papers · 987 indexed · h-index 13

Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
Endocrinology top 5%
- Escherichia coli research studies 6
Oncology top 10%
- Cancer Cells and Metastasis 5
Ophthalmology top 5%
- Ocular Oncology and Treatments 3
Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 4
Infectious Diseases
- Viral gastroenteritis research and epidemiology 6
Biotechnology
- Listeria monocytogenes in Food Safety 3
Food Science
- Salmonella and Campylobacter epidemiology 2

Co-authors: Marc‐Henri Stern Olivier Lantz François‐Clément Bidard Jean‐Yves Pierga Aurore Rampanou Maud Milder Adrien Saliou Ronald Lebofsky
Cited by: Cancer Research Endocrinology Oncology
Partner nations: France United States Switzerland

In The Last Decade

Jordan Madic

18 papers receiving 970 citations

Peers

Countries citing papers authored by Jordan Madic

Since Specialization

Citations

This map shows the geographic impact of Jordan Madic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan Madic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan Madic more than expected).

Fields of papers citing papers by Jordan Madic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordan Madic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan Madic. The network helps show where Jordan Madic may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jordan Madic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jordan Madic Line = papers co-authored together Jordan Madic links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group Yann Ferret,Nicolas Boissel,Nathalie Hélevaut,Jordan Madic,Olivier Nibourel,Alice Marceau‐Renaut,Maxime Bucci,Sandrine Geffroy,Karine Celli‐Lebras,Sylvie Castaigné,Xavier Thomas,Christine Terré,Hervé Dombret,Claude Preudhomme,Aline Renneville	2018	34
2	EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR Jordan Madic,Cécile Jovelet,J Velazquez Lopez,Barbara André,Jean Fatien,Isabelle Miran,Aurélie Honoré,Laura Mezquita,Benjamin Besse,Ludovic Lacroix,Magali Droniou	2018	35
3	Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer Cécile Jovelet,Jordan Madic,Jordi Remón,Aurélie Honoré,Romain Girard,Étienne Rouleau,Barbara André,Benjamin Besse,Magali Droniou,Ludovic Lacroix	2017	26
4	Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Francesca Riva,François‐Clément Bidard,Alexandre Houy,Adrien Saliou,Jordan Madic,Aurore Rampanou,Caroline Hego,Maud Milder,Paul Cottu,Marie‐Paule Sablin,Anne Vincent‐Salomon,Olivier Lantz,Marc‐Henri Stern,Charlotte Proudhon,Jean‐Yves Pierga	2017	158
5	Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer Jean‐Yves Pierga,Francesca Riva,Alexandre Houy,Adrien Saliou,Jordan Madic,Aurore Rampanou,Caroline Hego,M. Milder,Paul Cottu,Marie‐Paule Sablin,Anne Vincent‐Salomon,Olivier Lantz,Marc‐Henri Stern,Charlotte Proudhon,F-C Bidard	2016	7
6	Three-color crystal digital PCR Jordan Madic,A. Zocevic,V. Senlis,Etienne Fradet,B. André,Stefan Müller,Rémi Dangla,Magali Droniou	2016	113
7	Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial F-C Bidard,Marc Ychou,Jordan Madic,Adrien Saliou,Olivier Bouché,Michel Rivoire,François Ghiringhelli,Éric François,Rosine Guimbaud,Laurent Mineur,Faiza Khemissa-Akouz,Thibault Mazard,Driffa Moussata,Wulfran Cacheux,Charlotte Proudhon,Marc‐Henri Stern,J-Y Pierga,Trevor Stanbury,Simon Thézenas,Pascale Mariani	2016	5
8	Abstract PD3-8: Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients François‐Clément Bidard,Jordan Madic,Anna Kiialainen,Fabian Birzele,Guillemette Ramey,Quentin Leroy,Thomas Rio Frio,Virginie Raynal,Virginie Bernard,Alban Lermine,Inga Clausen,Nicolas Giroud,Roland Schmucki,Carsten Horn,Olivia Spleiss,Olivier Lantz,Marc‐Henri Stern,Maja Weisser,Ronald Lebofsky,Jean‐Yves Pierga	2015	2
9	Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types Ronald Lebofsky,Charles Decraene,Virginie Bernard,Maud Kamal,Anthony Blin,Quentin Leroy,Thomas Rio Frio,Gaëlle Pierron,Céline Callens,Ivan Bièche,Adrien Saliou,Jordan Madic,Étienne Rouleau,François‐Clément Bidard,Olivier Lantz,Marc‐Henri Stern,Christophe Le Tourneau,Jean‐Yves Pierga	2014	216
10	Circulating tumor DNA (ctDNA) in metastatic uveal melanoma (MUM): Correlation with outcome in 87 patients (pts) from Institut Curie Sophie Piperno‐Neumann,Jordan Madic,Pascale Mariani,Aurore Rampanou,Vincent Servois,F-C Bidard,M. Milder,Nathalie Cassoux,Laurence Desjardins,Marc‐Henri Stern,Olivier Lantz	2013	1
11	Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma François‐Clément Bidard,Jordan Madic,Pascale Mariani,Sophie Piperno‐Neumann,Aurore Rampanou,Vincent Servois,Nathalie Cassoux,Laurence Desjardins,Maud Milder,Isabelle Vaucher,Jean‐Yves Pierga,Ronald Lebofsky,Marc‐Henri Stern,Olivier Lantz	2013	146
12	Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma Jordan Madic,Sophie Piperno‐Neumann,Vincent Servois,Aurore Rampanou,Maud Milder,Bénédicte Trouiller,David Gentien,Stéphanie Saada,Franck Assayag,Aurélie Thuleau,Fariba Némati,Didier Decaudin,François‐Clément Bidard,Laurence Desjardins,Pascale Mariani,Olivier Lantz,Marc‐Henri Stern	2012	65
13	Duplex real-time PCR detection of type III effector tccP and tccP2 genes in pathogenic Escherichia coli and prevalence in raw milk cheeses Jordan Madic,Carine Peytavin de Garam,Hubert Brugère,Estelle Loukiadis,Patrick Fach,Emmanuel Jamet,Frédéric Auvray	2011	4
14	A quantitative PCR assay for the detection and quantification of Shiga toxin-producing Escherichia coli (STEC) in minced beef and dairy products Sylviane Derzelle,A. Grine,Jordan Madic,Carine Peytavin de Garam,Noémie Vingadassalon,F. Dilasser,Emmanuel Jamet,Frédéric Auvray	2011	20
15	Detection of Shiga Toxin-Producing Escherichia coli Serotypes O26:H11, O103:H2, O111:H8, O145:H28, and O157:H7 in Raw-Milk Cheeses by Using Multiplex Real-Time PCR Jordan Madic,Noémie Vingadassalon,Carine Peytavin de Garam,Muriel Marault,Flemming Scheutz,Hubert Brugère,Emmanuel Jamet,Frédéric Auvray	2011	77
16	Simplex and multiplex real-time PCR assays for the detection of flagellar (H-antigen) fliC alleles and intimin (eae) variants associated with enterohaemorrhagic Escherichia coli (EHEC) serotypes O26:H11, O103:H2, O111:H8, O145:H28 and O157:H7 Jordan Madic,Carine Peytavin de Garam,Noémie Vingadassalon,Éric Oswald,Patrick Fach,Emmanuel Jamet,Frédéric Auvray	2010	39
17	Screening of food raw materials for the presence of Shiga toxin-producingEscherichia coliO91:H21 Jordan Madic,C. Lecureuil,F. Dilasser,Sylviane Derzelle,Emmanuel Jamet,Patrick Fach,Frédéric Auvray	2009	14
18	Biotic and Abiotic Factors Influencing In Vitro Growth of Escherichia coli O157:H7 in Ruminant Digestive Contents Frédérique Chaucheyras‐Durand,Jordan Madic,F Doudin,Christine Martin	2006	25

About Jordan Madic

Jordan Madic is a scholar working on Endocrinology, Cancer Research and Biotechnology, having authored 18 papers that have together received 987 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Viral gastroenteritis research and epidemiology (6 papers), Escherichia coli research studies (6 papers), Cancer Cells and Metastasis (5 papers), Genetic factors in colorectal cancer (4 papers), Ocular Oncology and Treatments (3 papers), Listeria monocytogenes in Food Safety (3 papers) and Salmonella and Campylobacter epidemiology (2 papers). The work is most often cited by research in Cancer Research (542 citations), Endocrinology (150 citations) and Oncology (300 citations). Jordan Madic has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Marc‐Henri Stern, Olivier Lantz, François‐Clément Bidard, Jean‐Yves Pierga, Aurore Rampanou, Maud Milder, Adrien Saliou, Ronald Lebofsky, Emmanuel Jamet and Frédéric Auvray.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact